Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery
CONCLUSIONS: Low-certainty evidence suggests that NSAIDs may reduce postoperative pain, nausea and vomiting, and postoperative opioid use. However, there was very little evidence to indicate whether NSAIDs affect the rate of breast hematoma or bleeding from any location within 90 days of breast surgery, the need for blood transfusion and incidence of other side effects compared to placebo or other analgesics. High-quality large-scale RCTs are required before definitive conclusions can be made.PMID:34753201 | DOI:10.1002/14651858.CD013290.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Kevin M Klifto Ala Elhelali Rachael M Payne Carisa M Cooney Michele A Manahan Gedge D Rosson Source Type: research
More News: Bleeding | Blood Transusion | Breast Cancer | Breast Surgery | Cancer | Cancer & Oncology | Celebrex | Clinical Trials | Databases & Libraries | Diclofenac | Fentanyl | General Medicine | Hydrocodone | Ibuprofen | Morphine | Pain | Study | Voltaren | Women